Chymotrypsin PCD Pharma Franchise Company

Cafoli Lifecare offers a Chymotrypsin range of 4 tablet formulations, manufactured in WHO-GMP certified facilities. Distributors serving surgical, orthopaedic, ENT and dental prescribers can secure district-wise monopoly franchise rights for this proteolytic anti-inflammatory enzyme with full promotional support.

What is Chymotrypsin?

Chymotrypsin is a proteolytic enzyme that breaks down proteins and is used - most often in a trypsin-chymotrypsin combination - for its anti-inflammatory, anti-oedema and wound-healing effects. It helps reduce swelling and speed resolution of tissue injury after trauma and surgery. Reference: PubChem - Chymotrypsin.

Available Forms

The Cafoli Chymotrypsin portfolio is offered as oral Tablets, most commonly as trypsin-chymotrypsin enzyme combinations. Contact us for current pack presentations and combinations.

Therapeutic Applications

Chymotrypsin enzyme tablets are used to reduce post-traumatic and post-surgical swelling and inflammation, aid wound and soft-tissue healing, and control oedema in dental, orthopaedic and ENT conditions. Prescribers include surgeons, orthopaedic surgeons, dental surgeons, ENT specialists and gynaecologists.

Why Chymotrypsin is a High-Potential Molecule for Distributors

Anti-inflammatory enzyme tablets are a standard co-prescription after almost every surgery, dental extraction, injury and delivery, making them a natural companion to the large surgical and ortho prescription pool. As defined-course, healthy-margin add-ons prescribed across many busy specialties, chymotrypsin combinations deliver reliable per-prescription value for distributors.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. PubChem: Chymotrypsin
2. PubMed: trypsin-chymotrypsin in inflammation and oedema
3. PMC: proteolytic enzymes in wound healing